LY503430, a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor potentiator with functional, neuroprotective and neurotrophic effects in rodent models of Parkinson's disease. (Q34194729)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q47697406)
(P304) 752-762
(P407) (Q1860)
(P433) 2
(P478) 306
(P577) Friday, May 2, 2003
(P921) (Q11085)
(P1433) (Q1500272)
(P1476) "LY503430, a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor potentiator with functional, neuroprotective and neurotrophic effects in rodent models of Parkinson's disease" (language: en)
(P2093) Tracey K Murray
Christine S Robinson
Mark A Ward
Caroline A Hicks
David Lodge
Jim L Vandergriff
Polly Baumbarger
Edward Siuda
Mary Gates
Ann M Ogden
Phil Skolnick
Dennis M Zimmerman
Eric S Nisenbaum
David Bleakman
Michael J O'Neill
other details
description scientific article

External Links